Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imaging Biomarkers of Pancreatic Function and Disease
NCT05659147Phase 4Enrolling by invitation
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Jan 2023
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Phase 4, open-label trial (5 arms), sponsored by Cincinnati Children's Hospital Medical Center. Primary endpoints: Pancreas volume as a predictor of pancreas health and function at 5 years, Pancreas T1 signal as a predictor of pancreas health and function at 5 years and 2 more. Started Jan 2023; status: enrolling by invitation.
Beyond the preview
Go deeper on NCT05659147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05659147.